Levocetirizina Fair-Med

Levocetirizine, the active ingredient in Levocetirizina Fair-Med, is an antihistamine presented as an oral tablet for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in both adults and children.

GNH USA supplies Levocetirizina Fair-Med as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine acts on histamine‑mediated allergic pathways and is used to manage several common allergic conditions.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. Chronic idiopathic urticaria: alleviates hives and associated itching. Seasonal allergic conjunctivitis: eases eye itching, redness and tearing.

Levocetirizine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Drowsiness or fatigue - Dry mouth - Headache - Nausea - Altered taste perception - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Angioedema or severe swelling - Anaphylactic reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic enzyme elevation - Hematologic abnormalities (e.g., eosinophilia) - Cardiac arrhythmias

Before initiating therapy, consider the following safety measures.

Renal function assessment: dose may need adjustment in severe impairment. Known hypersensitivity: avoid if the patient has previously reacted to levocetirizine or other piperazine antihistamines. Pregnancy and lactation: use only if clearly needed and after risk‑benefit evaluation. Sedation risk: caution when operating machinery or driving. Alcohol and CNS depressants: avoid concurrent use to reduce additive drowsiness. Store below 25°C: keep in the original pack, protect from moisture.

Levocetirizine may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Alcohol: may potentiate sedation and impair cognition. - Other antihistamines: additive antihistaminic effect can increase drowsiness. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma concentrations.

Moderate Interactions (Monitor Closely): - Theophylline: possible increase in theophylline‑related side effects. - Ritonavir: may modestly elevate levocetirizine levels. - Certain antidepressants (e.g., tricyclics): monitor for enhanced anticholinergic effects.